172 related articles for article (PubMed ID: 10942532)
1. Ki-ras and the characteristics of mouse lung tumors.
Ramakrishna G; Bialkowska A; Perella C; Birely L; Fornwald LW; Diwan BA; Shiao YH; Anderson LM
Mol Carcinog; 2000 Jul; 28(3):156-67. PubMed ID: 10942532
[TBL] [Abstract][Full Text] [Related]
2. Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Ramakrishna G; Perella C; Birely L; Diwan BA; Fornwald LW; Anderson LM
Toxicol Appl Pharmacol; 2002 Feb; 179(1):21-34. PubMed ID: 11884234
[TBL] [Abstract][Full Text] [Related]
3. Ki-ras gene mutations and absence of p53 gene mutations in spontaneous and urethane-induced early lung lesions in CBA/J mice.
Cazorla M; Hernández L; Fernández PL; Fabra A; Peinado MA; Dasenbrock C; Tillmann T; Kamino K; Campo E; Kohler M; Morawieltz G; Cardesa A; Tomatis L; Mohr U
Mol Carcinog; 1998 Apr; 21(4):251-60. PubMed ID: 9585255
[TBL] [Abstract][Full Text] [Related]
4. K-ras p21 expression and activity in lung and lung tumors.
Ramakrishna G; Sithanandam G; Cheng RY; Fornwald LW; Smith GT; Diwan BA; Anderson LM
Exp Lung Res; 2000 Dec; 26(8):659-71. PubMed ID: 11195463
[TBL] [Abstract][Full Text] [Related]
5. Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas.
Nuzum EO; Malkinson AM; Beer DG
Mol Carcinog; 1990; 3(5):287-95. PubMed ID: 2244961
[TBL] [Abstract][Full Text] [Related]
6. Ki-ras activation and expression in transformed mouse lung cell lines.
Pan YH; Nuzum EO; Hanson LA; Beer DG
Mol Carcinog; 1990; 3(5):279-86. PubMed ID: 2244960
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of transplacentally induced mouse lung tumors.
Miller MS; Leone-Kabler S; Rollins LA; Wessner LL; Fan M; Schaeffer DO; McEntee MF; O'Sullivan MG
Exp Lung Res; 1998; 24(4):557-77. PubMed ID: 9659583
[TBL] [Abstract][Full Text] [Related]
8. Ki-ras mutation and cell proliferation of lung lesions induced by 1-nitropyrene in A/J mice.
Bai F; Nakanishi Y; Takayama K; Pei XH; Tokiwa H; Hara N
Mol Carcinog; 1998 Aug; 22(4):258-64. PubMed ID: 9726818
[TBL] [Abstract][Full Text] [Related]
9. Cyclopenta[cd]pyrene-induced tumorigenicity, Ki-ras codon 12 mutations and DNA adducts in strain A/J mouse lung.
Nesnow S; Ross JA; Nelson G; Wilson K; Roop BC; Jeffers AJ; Galati AJ; Stoner GD; Sangaiah R; Gold A
Carcinogenesis; 1994 Apr; 15(4):601-6. PubMed ID: 8149468
[TBL] [Abstract][Full Text] [Related]
10. Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.
Capella G; Cronauer-Mitra S; Pienado MA; Perucho M
Environ Health Perspect; 1991 Jun; 93():125-31. PubMed ID: 1685441
[TBL] [Abstract][Full Text] [Related]
11. Activation of MEK1/2-ERK1/2 signaling during NNK-induced lung carcinogenesis in female A/J mice.
Yamakawa K; Yokohira M; Nakano Y; Kishi S; Kanie S; Imaida K
Cancer Med; 2016 May; 5(5):903-13. PubMed ID: 26864819
[TBL] [Abstract][Full Text] [Related]
12. Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.
Floyd HS; Farnsworth CL; Kock ND; Mizesko MC; Little JL; Dance ST; Everitt J; Tichelaar J; Whitsett JA; Miller MS
Carcinogenesis; 2005 Dec; 26(12):2196-206. PubMed ID: 16051643
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras.
McKenna IM; Ramakrishna G; Diwan BA; Kang Y; Shiao YH; Wakefield LM; Powell DA; Anderson LM; Jakowlew SB
Toxicol Lett; 2001 Sep; 123(2-3):151-8. PubMed ID: 11641043
[TBL] [Abstract][Full Text] [Related]
14. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.
You M; Candrian U; Maronpot RR; Stoner GD; Anderson MW
Proc Natl Acad Sci U S A; 1989 May; 86(9):3070-4. PubMed ID: 2654935
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
17. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
18. Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence.
Kammouni W; Ramakrishna G; Sithanandam G; Smith GT; Fornwald LW; Masuda A; Takahashi T; Anderson LM
Cell Growth Differ; 2002 Sep; 13(9):441-8. PubMed ID: 12354753
[TBL] [Abstract][Full Text] [Related]
19. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene.
Lin L; Festing MF; Devereux TR; Crist KA; Christiansen SC; Wang Y; Yang A; Svenson K; Paigen B; Malkinson AM; You M
Exp Lung Res; 1998; 24(4):481-97. PubMed ID: 9659579
[TBL] [Abstract][Full Text] [Related]
20. Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.
Parikh N; Shuck RL; Nguyen TA; Herron A; Donehower LA
Mol Cancer Res; 2012 Jun; 10(6):845-55. PubMed ID: 22532587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
